CUTISS won 4th place in this year’s jury-led TOP100 Swiss Startup Award, hosted by Venturelab. CUTISS won 1st in 2020 and 2nd place in 2021. In the Biotech sub-category, we continue to place 1st for the fourth years in a row now. We are proud of our team and thank you to the jury for their …
CUTISS reaches 4th place at TOP100 Swiss Startup Award Read More »
PRESS RELEASE CUTISS completes recruitment for denovoSkin™ Phase 2 clinical trial in adult and adolescent burn patients Switzerland, 7 September 2022 – CUTISS AG, a Swiss clinical-stage life sciences company focused on skin regenerative medicine and tissue engineering, has announced the completion of recruitment for the Phase 2 clinical trial of its lead product denovoSkin™ …
Recruitment completed for denovoSkin Phase 2 clinical trial, adult & adolescent patients Read More »
As part of the 25th anniversary celebrations of >>venture>>, Daniela contributed an opinion piece on how we can better nurture startups in Switzerland. Newsroom article le matin dimanche (French)
CUTISS is pleased to announce that a tissue graft patent has been granted by the European Patent Office for the personalized bioengineered human skin tissue therapy developed by CUTISS. The patent (3174563) has been granted pursuant to Article 97(1) EPC to University of Zurich (UZH) where the founders of CUTISS worked at the time of …
CUTISS granted European patent for skin tissue graft Read More »
The Swiss daily business newspaper Agefi published an interview with our CEO Daniela Marino following the announcement that CUTISS started onsite denovoSkin production, at its very own GMP facility. This is an exciting milestone for the company, resulting in greater production flexibility and scale-up opportunities. Newsroom Link to Interview
CUTISS achieves full independence in its manufacturing capabilities with onsite facility. Increased agility and capacity in producing denovoSkin for current and future clinical trials and patients on compassionate basis. Successful transfer of technology and departure from Wyss Zurich Translational Center, a joint accelerator created by Hansjörg Wyss together with the University of Zurich and ETH …
PRESS RELEASE Two innovative biotechnology specialists, IBSA Pharma and CUTISS complete license agreement for VitiCell® Agreement grants CUTISS exclusive worldwide license to commercialize VitiCell®. VitiCell® is a CE marked medical device developed by IBSA for the treatment of skin pigmentation disorders. Strategic fit with CUTISS’s expertise in skin tissue bioengineering. Sophia-Antipolis (France) and Zurich (Switzerland), 2 …
IBSA Pharma and CUTISS complete license agreement for VitiCell Read More »
CUTISS opens subsidiary in France and secures first government grant to extend its Research and Development in regenerative medicine The subsidiary CUTISS Innovation, based at Sophia Antipolis, Europe’s leading technology park, will focus on R&D and innovation in regenerative medicine. A grant of EUR 300,000 from the Region Provence-Alpes-Cote d’Azur will contribute towards the installation …
CUTISS opens R&D subsidiary in France and secures first grant Read More »
CUTISS’s first onsite manufacturing facility in Schlieren, Zurich, has received the certification of compliance for Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) from the regulator Swissmedic, the Swiss Agency for Therapeutic Products. The GMP and GDP certifications authorizes the collection, manufacturing, testing, storage, release, and distribution of Transplant Products (TpP), Gene Therapy (GT) …
Swissmedic grants CUTISS certificates of Good Manufacturing and Distribution Practices Read More »
Swiss national television RTS came to CUTISS recently to find out about the denovoSkin, and to hear from our CIO Vincent about the promising potential of automation to scale up skin tissue bioengineering. The CUTISS segment was broadcast as part of RTS’s business program T.T.C. (Toutes taxes comprises) and is available on playback (in French) …
CUTISS AG
CUTISS HAUS
Grabenstrasse 11
8952 Schlieren, Switzerland
info@cutiss.swiss
Tel. +41 44 244 36 60
Would you like to contact us as a journalist?
